Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cue Biopharma Inc CUE

Healthcare Biotechnology
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease... see more

Recent & Breaking News (NDAQ:CUE)

Cue Biopharma Strengthens Board of Directors with Addition of Fred Driscoll to Chair Audit Committee

GlobeNewswire June 28, 2018

Cue Biopharma to Host Investor Business Update Call and Webcast

GlobeNewswire May 10, 2018

Cue Biopharma to Present at Bloomberg Biotech Innovations Conference

GlobeNewswire April 5, 2018

Cue Biopharma to Present at BIO CEO & Investor Conference

Business Wire February 7, 2018

Cue Biopharma to Provide Corporate Update at the 10th Annual Biotech Showcase 2018 Conference

Business Wire January 4, 2018

Cue Biopharma Announces Closing of Initial Public Offering

Business Wire January 2, 2018